Canaccord Genuity Downgrades Intra-Cellular Therapies (ITCI) to Hold Jan 30, 2025 09:06PM
Intra-Cellular Therapies to Present at the Canaccord Genuity 44th Annual Growth Conference Aug 8, 2024 08:00AM
Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares Apr 24, 2024 04:01PM
Intra-Cellular Therapies (ITCI) PT Raised to $107 at Canaccord Genuity Apr 23, 2024 06:44AM
Intra-Cellular Therapies (ITCI) Prices Public Offering of Common Stock Apr 17, 2024 08:59PM


Apr 17, 2024 08:46PM Intra-Cellular Therapies Prices Public Offering of Common Stock
Aug 4, 2023 08:00AM Intra-Cellular Therapies to Present at the Canaccord Genuity 43rd Annual Growth Conference
Jan 7, 2022 04:01PM Intra-Cellular Therapies Announces Closing of $460 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Jan 5, 2022 06:04AM Intra-Cellular Therapies (ITCI) Prices 9.52M Share Offering at $42/sh
Jan 4, 2022 10:05PM Intra-Cellular Therapies Prices Public Offering of Common Stock
Dec 20, 2021 10:17AM Intra-Cellular Therapies (ITCI) PT Raised to $88 at Canaccord Genuity Following FDA Approval
Aug 10, 2021 08:00AM Intra-Cellular Therapies to Present at the Canaccord Genuity 41st Annual Growth Conference
Sep 11, 2020 05:52AM Intra-Cellular Therapies (ITCI) Prices 11.67M Share Common Offering at $30/Sh
Sep 10, 2020 08:30PM Intra-Cellular Therapies Prices Public Offering of Common Stock
Sep 9, 2020 04:54PM Intra-Cellular Therapies (ITCI) PT Raised to $80 at Canaccord Genuity
Jan 8, 2020 05:54AM Intra-Cellular Therapies (ITCI) Prices 10M Share Common Offering at $29.50/Sh
Jan 7, 2020 09:47PM Intra-Cellular Therapies Prices Public Offering of Common Stock
Aug 6, 2019 08:00AM Intra-Cellular Therapies to Present at the Canaccord Genuity 39th Annual Growth Conference
Dec 15, 2017 05:34AM Canaccord Genuity Starts Intra-Cellular Therapies (ITCI) at Buy, 'Lumateperone on track as ITCI steadily builds a pipeline'
Oct 5, 2017 04:01PM Intra-Cellular Therapies Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock
Oct 2, 2017 04:01PM Intra-Cellular Therapies Announces Closing of $150 Million Public Offering of Common Stock
Sep 28, 2017 05:48AM Intra-Cellular Therapies (ITCI) Prices 9.68M Share Common Offering at $15.50/Sh
Sep 27, 2017 10:26PM Intra-Cellular Therapies Prices $150 Million Public Offering of Common Stock
Sep 27, 2017 09:23AM Pre-Open Stock Movers 09/27: (MARK) (CASC) (TWLO) Higher; (KRNT) (WLKP) (ITCI) Lower (more...)